OrbiMed Capital GP V LLC, 10% Owner at Loxo Oncology, Inc. (LOXO), bought 613,358 shares at $13.00 ($3.6M) on 2014-08-06, disclosed to the SEC on 2014-08-06.
Open-market purchase of $3.6M LOXO by 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.00 | 337,973 | $0 | 0.0% |
| 2 | $13.00 | 275,385 | $3.6M | 100.0% |
| Total | $5.84 avg | 613,358 | $3.6M | 100% |
| Filing → |
| CMPX | BUY | 2022-05-10 | $339K | — | Filing → |
| CRVS | SELL | 2021-09-22 | $13.5M | — | Filing → |
| ARPO | SELL | 2020-12-10 | $42K | — | Filing → |